Tag: GLP-1
Zydus plans to launch innovative Semaglutide Injection in India on Day...
The company has developed an innovative Semaglutide Injection (15 mg/3 ml) in a prefilled cartridge administered using a patient-friendly reusable pen for which the company has exclusive rights
Anti-obesity drugs to dominate biopharma trends in 2024, reports GlobalData
Survey reveals obesity medications as key driver for industry growth in biopharmaceutical sector
Novo Nordisk India launches world’s only peptide in a pill for...
Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an oral formulation for the first time